Operating margin moved 968 bp higher
Operating margin changed +968 basis points from the comparable as-filed period.
32.96%→42.64%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FSLR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 24.6%
Operating income changed +24.6% from the comparable as-filed period.
$361.6M→$450.4M3 prior comparisons
Gross margin moved 1172 bp higher
Gross margin changed +1172 basis points from the comparable as-filed period.
45.56%→57.28%3 prior comparisons
Cash & equivalents increased 50.1%
Cash & equivalents changed +50.1% from the comparable as-filed period.
$1.1B→$1.7B2 prior comparisons
Net income increased 23.6%
Net income changed +23.6% from the comparable as-filed period.
$341.9M→$422.6M3 prior comparisons
Research & development increased 39.9%
Research & development changed +39.9% from the comparable as-filed period.
$54.5M→$76.2M3 prior comparisons
Inventory / revenue moved 2586 bp lower
Inventory / revenue changed -2586 basis points from the comparable as-filed period.
128.88%→103.02%3 prior comparisons
Inventory decreased 23.0%
Inventory changed -23.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.4B→$1.1B4 prior comparisons
Revenue decreased 3.7%
Revenue changed -3.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$1.1B→$1.1B3 prior comparisons
Gross profit increased 21.0%
Gross profit changed +21.0% from the comparable as-filed period.
$499.9M→$605.0M3 prior comparisons
SBC / revenue moved 5 bp higher
SBC / revenue changed +5 basis points from the comparable as-filed period.
0.62%→0.67%3 prior comparisons
Selling, general & administrative decreased 1.2%
Selling, general & administrative changed -1.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$52.6M→$51.9M3 prior comparisons
Stock-based compensation increased 3.5%
Stock-based compensation changed +3.5% from the comparable as-filed period.
$6.8M→$7.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.